References
Murdoch D & McTavish D. Drugs 44: 604–624, 1992
McTavish D & Benfield P. Drugs 39: 136–153, 1990
Fitton A, et al. Drugs 43: 561–596, 1992
Bersani G, et al. Eur Neuropsychopharmacol 1: 444, 1991
Fabre LF, et al. Submitted to Br J Psychiatry, 1992
Reimherr FW, et al. J Clin Psychiatry 51 (Suppl. B): 18–27, 1990
Langdon CG. Eur Neuropsychopharmacol 1: 445, 1992
Fontaine R, et al. Eur Neuropsychopharmacol 1: 447, 1992
Cohn CK, et al. J Clin Psychiatry 51 (Suppl. B): 28–33, 1990
Montgomery SA, et al. Int Clin Psychopharmacol 6 (Suppl. 2): 37–46, 1991
Doogan DP & Caillard V. Br J Psychiatry 160: 217–222, 1992
Greist JH. J Clin Psychiatry 51 (Suppl.): 44–50, 1990
Chouinard G, et al. Psychopharmacol Bull 26: 279–284, 1990
Greist J, et al. Eur Neuropsychopharmacol 2: 386, 1992
Doogan DP. Int Clin Psychopharmacol 6 (Suppl.2): 47–56, 1991
Guy S & Silke B. J Clin Psychiatry 51 (Suppl. B): 37–39, 1990
Brown WA & Harrison W. Psychopharmacol Bull 28: 253–256, 1992
British National Formulary 24: 508, 1992
Rights and permissions
About this article
Cite this article
Sertraline: Effective, Safe and Expensive in Depression and Obsessive-Compulsive Disorder. Drugs Ther. Perspect 1, 1–4 (1993). https://doi.org/10.2165/00042310-199301040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199301040-00001